T2 BIOSYSTEMS, INC.: other noncurrent liabilities

What this measure means

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Exact concept: us-gaap:OtherLiabilitiesNoncurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2014-12-31 to 2021-12-31. The SEC response was captured on 2026-09-21.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Selected filing history

Related financial histories

• T2 BIOSYSTEMS, INC.: total assets
• T2 BIOSYSTEMS, INC.: total liabilities
• T2 BIOSYSTEMS, INC.: stockholders equity
• T2 BIOSYSTEMS, INC.: cash and cash equivalents
• T2 BIOSYSTEMS, INC.: net income or loss
• T2 BIOSYSTEMS, INC.: operating cash flow
• T2 BIOSYSTEMS, INC.: capital expenditure payments
• T2 BIOSYSTEMS, INC.: contract revenue excluding tax
• T2 BIOSYSTEMS, INC.: financing cash flow
• T2 BIOSYSTEMS, INC.: investing cash flow
• T2 BIOSYSTEMS, INC.: retained earnings or deficit
• T2 BIOSYSTEMS, INC.: basic weighted-average shares
• T2 BIOSYSTEMS, INC.: diluted weighted-average shares
• T2 BIOSYSTEMS, INC.: basic earnings per share
• T2 BIOSYSTEMS, INC.: diluted earnings per share
• T2 BIOSYSTEMS, INC.: net property, plant and equipment
• T2 BIOSYSTEMS, INC.: share-based compensation expense
• T2 BIOSYSTEMS, INC.: operating income or loss
• T2 BIOSYSTEMS, INC.: current assets
• T2 BIOSYSTEMS, INC.: interest expense
• T2 BIOSYSTEMS, INC.: current liabilities
• T2 BIOSYSTEMS, INC.: current accounts payable
• T2 BIOSYSTEMS, INC.: net current accounts receivable
• T2 BIOSYSTEMS, INC.: operating expenses
• T2 BIOSYSTEMS, INC.: net inventory
• T2 BIOSYSTEMS, INC.: selling, general and administrative expense
• T2 BIOSYSTEMS, INC.: research and development expense
• T2 BIOSYSTEMS, INC.: common shares outstanding
• T2 BIOSYSTEMS, INC.: operating lease right-of-use asset
• T2 BIOSYSTEMS, INC.: operating lease liability
• T2 BIOSYSTEMS, INC.: gross property, plant and equipment
• T2 BIOSYSTEMS, INC.: accumulated depreciation on property, plant and equipment
• T2 BIOSYSTEMS, INC.: other noncurrent assets
• T2 BIOSYSTEMS, INC.: accrued current liabilities
• T2 BIOSYSTEMS, INC.: prepaid expenses and other current assets
• T2 BIOSYSTEMS, INC.: current contract liabilities
• T2 BIOSYSTEMS, INC.: net deferred tax assets
• T2 BIOSYSTEMS, INC.: profit or loss including noncontrolling interests
• T2 BIOSYSTEMS, INC.: comprehensive income or loss
• T2 BIOSYSTEMS, INC.: net income available to common stockholders
• T2 BIOSYSTEMS, INC.: depreciation, depletion and amortization
• T2 BIOSYSTEMS, INC.: other nonoperating income or expense
• T2 BIOSYSTEMS, INC.: nonoperating income or expense
• T2 BIOSYSTEMS, INC.: interest paid, net
• T2 BIOSYSTEMS, INC.: change in accounts receivable
• T2 BIOSYSTEMS, INC.: change in inventories
• T2 BIOSYSTEMS, INC.: change in accounts payable

Inspect the source

Entity

T2 BIOSYSTEMS, INC. / CIK 0001492674

Captured

2026-09-21T17:19:25.418Z

SEC response SHA-256

dbd07ba31dbcb85fa14a2ccff083f2b47da4b8934cb86029b7a4f3285d16fc05

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001492674.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))